The company
Myomo Inc.
MYO · NYSE American
MYO stood above a rising 150-day average in 20 of the last 52 weekly readings, including each of the last 20 weeks. It is 9.7% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 20 in a row
- Industry in uptrend
- 29% -4 in 4 wk
- Insider buys, 12 months
- $876K
- Insider sales, 12 months
- $442K
- Officials’ trades on record
- 0
- Institutions holding
- 76 (+3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Harry KovelmanChief Medical Officer | sold | 15,488at $1.27 | 11 Sep 2026filed 14 Sep 2026 |
| Harry KovelmanChief Medical Officer | sold | 15,844at $1.27 | 11 Sep 2026filed 15 Oct 2026 |
| Milton Mayo MorrisDirector | sold | 15,000at $1.41 | 2 Sep 2026filed 4 Sep 2026 |
| Harry KovelmanChief Medical Officer | sold | 17,250at $1.73 | 20 Aug 2026filed 21 Aug 2026 |
| Harry KovelmanChief Medical Officer | sold | 17,500at $1.73 | 20 Aug 2026filed 24 Aug 2026 |
| Thomas F. KirkDirector | bought | 40,002at $1.27 | 5 Jun 2026filed 9 Jun 2026 |
| Harry KovelmanChief Medical Officer | sold | 11,536at $1.02 | 28 May 2026filed 28 May 2026 |
| Thomas F. KirkDirector | bought | 25,000at $0.993 | 28 May 2026filed 1 Jun 2026 |
| Harry KovelmanChief Medical Officer | sold | 20,464at $1.00 | 27 May 2026filed 28 May 2026 |
| Thomas F. KirkDirector | bought | 43,401at $0.91 | 18 May 2026filed 18 May 2026 |
| Thomas F. KirkDirector | bought | 31,605at $0.9096 | 15 May 2026filed 18 May 2026 |
| Joseph M. Manko, Jr.Director | bought | 30,367at $0.8878 | 15 May 2026filed 18 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Rosalind Advisors, Inc.reduced · filed 14 Aug 2026 | 3,637,886$3.8M | -209,386−5.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,636,570$1.7M | +492,246+43.0% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 928,268$965K | +609,317+191.0% |
| Jefferies Financial Group Inc.unchanged · filed 17 Aug 2026 | 704,275$732K | 00.0% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 596,352$620K | +596,352 |
| Clearstead Advisors, LLCadded · filed 6 Aug 2026 | 425,609$443K | +90.0% |
| UBS Group AGadded · filed 13 Aug 2026 | 413,679$430K | +101,958+32.7% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 344,417$358K | -514,382−59.9% |
| LPL Financial LLCadded · filed 7 Aug 2026 | 308,000$320K | +2,000+0.7% |
| Palumbo Wealth Management LLCnew · filed 12 Aug 2026 | 299,776$312K | +299,776 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.